TREM2 and Alzheimer disease: Cerebrospinal fluid-soluble TREM2 is notably elevated in the early stages of AD, but its levels tend to decrease as AD progresses [30,35,36,37], and is presumed to hold important regulatory functions in the extracellular environment through its interaction with biomolecules in the cerebrospinal fluid [38].